BR9608909A - Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto - Google Patents

Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto

Info

Publication number
BR9608909A
BR9608909A BR9608909A BR9608909A BR9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A
Authority
BR
Brazil
Prior art keywords
animals
compound
increase
growth
patuitaria
Prior art date
Application number
BR9608909A
Other languages
English (en)
Portuguese (pt)
Inventor
Henning Thoegersen
Thomas Kruse Hansen
Jesper Lau
Nils Johansen Langeland
Behrend Friedrich Lundt
Kjeld Madsen
Birgit Sehested Hansen
Bernd Peschke
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9608909A publication Critical patent/BR9608909A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR9608909A 1995-06-22 1996-06-19 Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto BR9608909A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK71995 1995-06-22
DK137195 1995-12-04
PCT/DK1996/000266 WO1997000894A1 (en) 1995-06-22 1996-06-19 Compounds with growth hormone releasing properties

Publications (1)

Publication Number Publication Date
BR9608909A true BR9608909A (pt) 1999-03-02

Family

ID=26064522

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608909A BR9608909A (pt) 1995-06-22 1996-06-19 Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto

Country Status (12)

Country Link
EP (1) EP0833845A1 (hu)
KR (1) KR19990028303A (hu)
AU (1) AU711104B2 (hu)
BR (1) BR9608909A (hu)
CA (1) CA2224434A1 (hu)
CZ (1) CZ287948B6 (hu)
HU (1) HUP9802821A3 (hu)
IL (1) IL122371A0 (hu)
NO (1) NO975992L (hu)
PL (1) PL186520B1 (hu)
TW (1) TW458958B (hu)
WO (1) WO1997000894A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008492A1 (en) * 1996-08-29 1998-03-05 Novo Nordisk A/S Transdermal delivery of peptides
EP1005484A1 (en) 1997-06-20 2000-06-07 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6127341A (en) * 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
CN1213036C (zh) 1997-08-22 2005-08-03 科研制药株式会社 新的酰胺类衍生物
AU766305B2 (en) 1998-01-16 2003-10-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
EA003860B1 (ru) * 1998-05-12 2003-10-30 Варнер-Ламберт Компани КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
KR100907638B1 (ko) * 1998-06-30 2009-07-14 노보 노르디스크 에이/에스 성장 호르몬 방출성을 가지는 화합물
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6468974B1 (en) 1998-08-14 2002-10-22 The Administrators Of The Tulane Educational Fund Compounds having growth hormone releasing activity
AU759022B2 (en) 1999-02-18 2003-04-03 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
EP1343751A2 (en) 2000-12-20 2003-09-17 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
JP2005506949A (ja) 2000-12-20 2005-03-10 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー ケモカイン受容体の調節剤としてのジアミン
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
US8138191B2 (en) 2007-01-11 2012-03-20 Critical Outcome Technologies Inc. Inhibitor compounds and cancer treatment methods
ES2604943T3 (es) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos
US8466151B2 (en) 2007-12-26 2013-06-18 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
HU224345B1 (hu) * 1993-12-23 2005-08-29 Novo Nordisk A/S. Növekedési hormont felszabadító tulajdonságú peptidek, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues

Also Published As

Publication number Publication date
EP0833845A1 (en) 1998-04-08
MX9710377A (es) 1998-03-29
CZ287948B6 (cs) 2001-03-14
IL122371A0 (en) 1998-06-15
WO1997000894A1 (en) 1997-01-09
CZ408197A3 (cs) 1998-05-13
KR19990028303A (ko) 1999-04-15
PL324200A1 (en) 1998-05-11
JPH11507928A (ja) 1999-07-13
CA2224434A1 (en) 1997-01-09
TW458958B (en) 2001-10-11
NO975992D0 (no) 1997-12-19
NO975992L (no) 1998-02-20
HUP9802821A2 (hu) 1999-03-29
PL186520B1 (pl) 2004-01-30
HUP9802821A3 (en) 2000-03-28
AU6188296A (en) 1997-01-22
JP4173541B2 (ja) 2008-10-29
AU711104B2 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
BR9608909A (pt) Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto
BR9608956A (pt) Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto
PT912194E (pt) Formula de vacina polinucleotidica particularmente contra doenca respiratoria dos bovinos
ATE178204T1 (de) Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer
BR9608908A (pt) Composto composição farmacêutica processos para aliviar dor e para preparar um composto
DE3876756T2 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
BR9609670A (pt) Compostos processos para a preparação dos mesmos uso dos mesmos e processos de controlar pestes fúngicidas e pestes animais
DE68916430D1 (de) Arzneimittelzubereitung zur behandlung von mastitis bei tier und mensch.
BR9605907A (pt) Formulaçao de liberaçao prolongada de um hormônio de crescimento animal e processo para sua preparaçao
ITMI951538A0 (it) Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica
PT801561E (pt) Composicao e metodos para a entrega transdermica de drogas labeis a acido
FR2748394B1 (fr) Applicateur de medicaments pour animaux
BR9603012A (pt) Composição de resina produto moldado coleira brinco e medalha para animais processo para controlar a exsudação do composto ativo e uso do produto moldado
BR9506235A (pt) Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica
FI972949A (fi) Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä
BR9709930A (pt) Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
BR9612362A (pt) Compostos produto adequado para o controle de pragas animais ou de oragas fúgidas processos para o controle de pragas fúngidas e animais e para a preparação dos compostos utilização dos compostos e produtos intermediários
AU1581795A (en) Lure for facilitating the administration of drugs to certain animals, particularly dogs
BR9200318A (pt) Derivados de 3-aril-pirrolidin-2,4-diona biciclicos-substituidos,processo para a sua preparacao,composicoes praguicidas,processo para o combate de pragas animais,aplicacao dos ditos derivados,processo para a preparacao de praguicidas,processo para o combate de ervas daninhas e processo para a preparacao de composicoes herbicidas
ATE292458T1 (de) Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2- pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze
FR2739778B1 (fr) Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
BR9501691A (pt) Derivado de ácido graxo processo para a preparação de um derivado de ácido graxo composição farmacêutica e método para a prevenção e ou tratamento de doenças humanas ou animais
FR2683147B1 (fr) Systeme vehicule de principe actif permettant l'administration voie orale chez les poissons et crustaces.
BR8804221A (pt) Processo para a preparacao de um composto,composicoes praguicidas,aplicacao,processo para combater pragas em animais e plantas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements